MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-24-2026
AdaptHealth Corp. Operating Income 2011-2026 | AHCO
Operating profit (also called operating income or profit from core activities) is a financial metric that reflects a company's profit from its main operational activities before interest expenses and taxes are taken into account.
FormulaOperating profit = Revenue – Operating expensesFeatures of the metric
- Evaluates business efficiency
Shows how well the company controls its production and administrative costs. - Independent of financial structure
Excludes the impact of debt burden (interest) and taxes, allowing objective comparison of companies. - Main source for growth
High operating profit provides resources for investments, business expansion, and increased competitiveness.
If a company shows strong operating profit, it signals to investors that the core business is operating efficiently, even if net profit is temporarily reduced due to debt or tax burden.
Annual Operating Income AdaptHealth Corp.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 90.9 M | 264 M | -598 M | 190 M | 226 M | 71.3 M | 29.4 M | 31.1 M | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 264 M | -598 M | 38 M |
Quarterly Operating Income AdaptHealth Corp.
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 61.7 M | 79.3 M | 23.2 M | - | 63.5 M | 52 M | 50.5 M | - | -461 M | 54.3 M | 26.2 M | - | 52.9 M | 59.2 M | 51.6 M | - | 75.7 M | 65.4 M | 15.4 M | - | 13.3 M | 15.6 M | 8.22 M | - | 8.72 M | 14.9 M | 5.35 M | - | -445 K | -234 K | -72.5 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 79.3 M | -461 M | 14 M |
Operating Income of other stocks in the Medical devices industry
| Issuer | Operating Income | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
EDAP TMS S.A.
EDAP
|
-20.5 M | $ 3.28 | - | $ 123 M |  France |
 |
Electromed
ELMD
|
9.66 M | $ 25.74 | - | $ 218 M |  USA |
 |
Apollo Endosurgery
APEN
|
-31.4 M | - | - | $ 475 M | USA |
 |
Globus Medical
GMED
|
480 M | $ 90.74 | - | $ 12.3 B | USA |
 |
Helius Medical Technologies
HSDT
|
-12.4 M | $ 2.08 | - | $ 1.26 M | USA |
 |
Aziyo Biologics
AZYO
|
-26.9 M | - | 1.37 % | $ 20.5 M | USA |
 |
Allied Healthcare Products
AHPI
|
-1.27 M | - | 3.58 % | $ 2.21 M | USA |
 |
Avinger
AVGR
|
-16.6 M | - | -20.74 % | $ 369 K | USA |
 |
BIOLASE
BIOL
|
-17.9 M | - | -13.19 % | $ 166 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
-64.9 M | - | - | $ 3.31 B | USA |
 |
Pulmonx Corporation
LUNG
|
-53.7 M | $ 1.23 | - | $ 50 M | USA |
 |
BioSig Technologies
BSGM
|
-71.1 M | - | 37.08 % | $ 85.7 M | USA |
 |
Orthofix Medical
OFIX
|
-81.4 M | $ 11.91 | - | $ 472 M |  Curacao |
 |
Conformis
CFMS
|
-46.3 M | - | - | $ 16.4 M | USA |
 |
Insulet Corporation
PODD
|
474 M | $ 182.87 | - | $ 12.9 B | USA |
 |
Cardiovascular Systems
CSII
|
-35.8 M | - | 0.15 % | $ 844 M | USA |
 |
Cytosorbents Corporation
CTSO
|
-14.7 M | $ 0.6 | -1.96 % | $ 37.3 M | USA |
 |
Sintx Technologies
SINT
|
-10.7 M | $ 2.15 | - | $ 5.96 M | USA |
 |
ClearPoint Neuro
CLPT
|
-24.2 M | $ 11.08 | - | $ 314 M | USA |
 |
Dynatronics Corporation
DYNT
|
-2.45 M | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
-112 M | - | - | $ 10.2 M | USA |
 |
Stryker Corporation
SYK
|
4.89 B | $ 321.43 | -0.02 % | $ 123 B | USA |
 |
Tactile Systems Technology
TCMD
|
29.3 M | $ 23.57 | - | $ 539 M | USA |
 |
TELA Bio
TELA
|
-33.8 M | $ 0.78 | - | $ 36.6 M | USA |
 |
Second Sight Medical Products
EYES
|
-27.6 M | - | -0.97 % | $ 54.4 M | USA |
 |
TransMedics Group
TMDX
|
109 M | $ 101.26 | - | $ 3.44 B | USA |
 |
Tandem Diabetes Care
TNDM
|
8.29 M | $ 18.63 | - | $ 1.27 B | USA |
 |
GBS
GBS
|
-10.6 M | - | -0.57 % | $ 7.12 M | USA |
 |
Neovasc
NVCN
|
-31.1 M | - | - | $ 111 M |  Canada |
 |
Varex Imaging Corporation
VREX
|
-27.8 M | $ 12.07 | - | $ 500 M | USA |
 |
Butterfly Network
BFLY
|
-74.4 M | $ 5.16 | - | $ 1.09 B | USA |
 |
Vivos Therapeutics
VVOS
|
-19.9 M | $ 0.85 | - | $ 8.73 M | USA |
 |
Beyond Air
XAIR
|
-44.5 M | $ 0.51 | - | $ 34.5 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
-39.2 M | $ 15.14 | - | $ 355 M | USA |
 |
Delcath Systems
DCTH
|
660 K | $ 10.55 | - | $ 378 M | USA |
 |
Xtant Medical Holdings
XTNT
|
7.28 M | $ 0.55 | -1.78 % | $ 76.7 M | USA |
 |
Zimmer Biomet Holdings
ZBH
|
1.29 B | $ 82.8 | - | $ 16.8 B | USA |
 |
IRIDEX Corporation
IRIX
|
-2.57 M | $ 1.04 | - | $ 17.6 M | USA |
 |
CONMED Corporation
CNMD
|
103 M | $ 36.79 | - | $ 1.14 B | USA |